The Ministry of Health should consider expanding the list of drug in Circular 10 in the direction of adding medicines with high technical standards, such as compliance with EU-GMP or equivalent standards, and medicines of high value, such as specialty drugs or specialized drugs; adding more criteria to confirm the effectiveness of the DD; strengthen inspection of the quality of DD.